Navigation Links
Quest Diagnostics Reports Strong Performance in Second Quarter 2009
Date:7/21/2009

c staff. Quest Diagnostics is a pioneer in developing innovative diagnostic tests and advanced healthcare information technology solutions that help improve patient care. Additional company information is available at www.QuestDiagnostics.com.

The statements in this press release which are not historical facts may be forward-looking statements. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date that they are made and which reflect management's current estimates, projections, expectations or beliefs and which involve risks and uncertainties that could cause actual results and outcomes to be materially different. Risks and uncertainties that may affect the future results of the company include, but are not limited to, adverse results from pending or future government investigations, lawsuits or private actions, the competitive environment, changes in government regulations, changing relationships with customers, payers, suppliers and strategic partners and other factors discussed in "Business" in Part I, Item 1, "Risk Factors" and "Cautionary Factors that May Affect Future Results" in Part I, Item 1A, "Legal Proceedings" in Part I, Item 3, "Management's Discussion and Analysis of Financial Condition and Results of Operations" in Part II, Item 7 and "Quantitative and Qualitative Disclosures About Market Risk" in Part II, Item 7A in the company's 2008 Annual Report on Form 10-K and "Management's Discussion and Analysis of Financial Condition and Results of Operations" and "Quantitative and Qualitative Disclosures About Market Risk" in the company's 2009 Quarterly Report on Form 10-Q and other items throughout the Form 10-K and the company's 2009 Quarterly Report on Form 10-Q and Current Reports on Form 8-K.

Estimated cash from operations before the payment of the previously announced NID settlement is
'/>"/>

SOURCE Quest Diagnostics
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. Effectiveness of mouse breeds that mimic Alzheimers disease symptoms questioned
2. The 7 Key Questions About the Schwarzenegger/Nunez Health Care Compromise
3. LifeQuest Announces End of Immunity Health Challenge Contest
4. LifeQuest World Corporation Proud Contributor to Dietary Supplement Education Alliance (DSEA)
5. Quest Diagnostics to Speak at the Bear Stearns Healthcare Conference
6. Study Questions Dead-End Cancer Clinical Trials
7. 6 Years Later, 9/11 Health Questions Linger
8. U.S. Physicians Question Presidential Candidates
9. RFID Implant Cancer Questions Concern Patients
10. Study Questions Genetic Screening for Treatable Diseases
11. Mass. Judge Denies Request by Breastfeeding Mother for More Break Time on Medical Licensing Exam
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... new report titled, “Incontinence Devices Markets Worldwide.” The report ... and manage urinary incontinence. , ... ... to announce the release of a new report titled, “Incontinence ... for clinical devices used to treat and manage urinary incontinence., ...
(Date:12/14/2009)... Attitudes and Behavior Regarding Pregnancy, Contraception, and Related Issues ... all unmarried young adults ages 18-29 believe pregnancy is ... 86% of women) and say that it is important ... of men and 88% of women), according to new ... and Unplanned Pregnancy. Even so: ,, Only ...
(Date:12/14/2009)... PARK, Ill. and HOLLYWOOD, Fla., Dec. 14 ... ) announced today a definitive agreement to ... ), a leading provider of laboratory information ... cash. ,, The acquisition strengthens Abbott,s ... providing advanced web-based applications to help laboratories ...
(Date:12/14/2009)... 14 The National Organization for Rare Disorders ... end to lifetime and annual health insurance caps. ... a newspaper distributed widely on Capitol Hill, NORD said ... would allow caps to continue for most Americans, contrary ... health care reform and welcomes the promises made by ...
(Date:12/14/2009)... under government controlled health care, before moving to the U.S. to ... in his new book, Health Reform: The End of the American ... and its threat to real health care! , ... ... radiologist from Minnesota, warns Americans not to sell out their liberty ...
Breaking Medicine News(10 mins):Health News:Urinary Incontinence Rates Increase Worldwide As Awareness Grows About Treatment Options: Urethral Slings Are Popular Alternatives When Medications Fail 2Health News:Urinary Incontinence Rates Increase Worldwide As Awareness Grows About Treatment Options: Urethral Slings Are Popular Alternatives When Medications Fail 3Health News:Although Most Unmarried Young Adults Want to Avoid Pregnancy, Many Don't Use Contraception, Know Little About It, and Think It Doesn't Make Much Difference 2Health News:Although Most Unmarried Young Adults Want to Avoid Pregnancy, Many Don't Use Contraception, Know Little About It, and Think It Doesn't Make Much Difference 3Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 2Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 3Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 4Health News:NORD Calls for Immediate End to Lifetime Insurance Caps 2Health News:Canadian Doctor Warns Against Government-Run, Socialized Medicine and its Threat to Health Care and Freedom in America 2
... made by Novartis AG and Fosamax manufactured by Merck and Co ... women users. Both are known bone-building drugs. ,The signs ... as an annual shot. But there was a hint of similar ... Fosamax by Merck & Co. They are all at risk for ...
... lift one out of depression. But its potential to ... ,Now the U.S. Food and Drug Administration (FDA) ... the existing black box warning on their products' labeling ... and behavior, in young adults ages 18 to 24 ...
... for enhancing sexual desire in female cancer survivors did not ... has shown. ,A low sex drive is ... previous study which pointed a link between androgen therapy and ... new study was conducted on 150 post menopausal cancer survivors. ...
... is a definite link between pregnancy, migraine and stroke, ... deadly one. ,In fact, Cheryl Bushnell, assistant ... Cerebrovascular Disease in Durham, explained that pregnant women who ... more than pregnant women who did not suffer migraine. ...
... cancer; a Danish study conducted amongst 28,000 workers in ... medical records were analyzed to monitor fresh cases of ... workers for 23years. This was done to ascertain the ... ,The researchers did not find any substantial ...
... older women - those 80 or older - have the greatest ... ,Worryingly, the research also found that 56 per cent ... risk. ,The strongest risk factor for breast cancer - ... risk. About one in 70 women will develop breast cancer between ...
Other Medicine News:Health News:Anti-osteoporosis Drugs Could Result in Irregular Heart Rhythm, New Study 2Health News:FDA Advisory Against Anti-depressants to Be Expanded to Cover Young Adults too 2Health News:FDA Advisory Against Anti-depressants to Be Expanded to Cover Young Adults too 3Health News:Women Unaware of When Breast Cancer Risk is Greatest 2
(Date:12/14/2009)... 14 Corgenix Medical Corporation (OTC ... marketer of diagnostic test kits, and BG ... sciences company, announced today a supply agreement ... products in enzyme-linked immunosorbent assay (ELISA) microtiter ... is seeking regulatory clearance in the United ...
(Date:12/14/2009)... Ga., Dec. 14 ... its flagship integrated EHR, Prime Suite ... CCHIT Certified(®) 2011 Ambulatory EHR, additionally certified ... optional Advanced Reporting. Greenway,s Prime Suite ... new 2011 certification designations offered by the ...
(Date:12/14/2009)... SAN FRANCISCO, Dec. 14 Environmental health ... promised announcement about health hazards of bisphenol A ... behavioral changes, reproductive harm and other illnesses, in ... MD, PhD , staff scientist, Natural ... on your doctor for medical advice, FDA must ...
Breaking Medicine Technology:Corgenix and BG Medicine Announce Supply Agreement for BGM Galectin-3(TM) 2Greenway Medical Technologies' PrimeSuite 2011 Receives CCHIT 2011 Comprehensive Certification 2Greenway Medical Technologies' PrimeSuite 2011 Receives CCHIT 2011 Comprehensive Certification 3Greenway Medical Technologies' PrimeSuite 2011 Receives CCHIT 2011 Comprehensive Certification 4Toxic Chemical bisphenol A Still Not Banned By FDA; Schumer, Gillibrand Call for Ban; Govt Official Warns Public 2Reportlinker Adds The Market for Minimally Invasive Medical Devices Report 56187 1Reportlinker Adds The Market for Minimally Invasive Medical Devices Report 56187 2Reportlinker Adds The Market for Minimally Invasive Medical Devices Report 56187 3Reportlinker Adds Botanical and Plant Derived Drugs 3A Global Markets Report 56183 1Reportlinker Adds Botanical and Plant Derived Drugs 3A Global Markets Report 56183 2Reportlinker Adds Botanical and Plant Derived Drugs 3A Global Markets Report 56183 3Reportlinker Adds Botanical and Plant Derived Drugs 3A Global Markets Report 56183 4Reportlinker Adds Smart Glass 3A Technologies and Global Markets Report 13840 1Reportlinker Adds Smart Glass 3A Technologies and Global Markets Report 13840 2Reportlinker Adds Smart Glass 3A Technologies and Global Markets Report 13840 3
... Pharmaceuticals LLC,announced today that their drug KX2-391 (KX01) ... entitled "A combined rising single-dose (RSD) and,rising multiple-dose ... pharmacokinetics of KX2-391 in patients with advanced malignancies ... to an emerging,new family of targeted cancer treatments ...
... Median Overall Survival vs. Interferon-Alpha, COLLEGEVILLE, Pa., ... (NYSE: WYE ), announced today that the,European ... of patients with advanced renal cell carcinoma (RCC),who ... factors. TORISEL is the only,approved cancer therapy that ...
Other Medicine Technology:First Patient Dosed with KX2-391 in Phase 1 Clinical Trial 2Wyeth's TORISEL Receives European Commission Approval for the Treatment of Advanced Kidney Cancer 2Wyeth's TORISEL Receives European Commission Approval for the Treatment of Advanced Kidney Cancer 3Wyeth's TORISEL Receives European Commission Approval for the Treatment of Advanced Kidney Cancer 4Wyeth's TORISEL Receives European Commission Approval for the Treatment of Advanced Kidney Cancer 5Wyeth's TORISEL Receives European Commission Approval for the Treatment of Advanced Kidney Cancer 6
... tests for Nystagmus when rotated at ... by 8" diameter. Light weight drum ... for effortless spin mechanism. For use ... Includes both Adult and Pediatric Drums ...
Eschenbach's new 2636 series of stand magnifiers delivers the benefits of high power and a large fields of view. Using a unique doublet lens design, the 2636 offers the highest power recatngular lens...
... This Illuminated Stand Magnifier offers versatility ... Both the lens and the light ... and small hand held objects can ... the lens parallel to the work ...
Bausch & Lomb magnifiers incorporates precision optics and patented ergonomic designs for increased clarity and comfort during use....
Medicine Products: